A Retrospective Database Analysis of an Ongoing Registry Study To Evaluate The Impact Of Daratumumab (Darzalex) Combined With Bortezomib-Dexamethasone (DVd) In Patients With Relapsed/Refractory Multiple Myeloma (RRMM) In Australia

Project: Research

Project Details

Short titleMRDR Janssen PRO Study
StatusActive
Effective start/end date1/05/2131/03/24

Funding

  • Janssen-Cilag Pty Ltd : AUD241,029.00

Keywords

  • sustainable development
  • Indo-Pacific
  • Global Sustainable Development Report
  • sustainability transformations
  • governance